Low dose vs high dose talc pleurodesis for malignant pleural effusion

R. S. Jha (New Delhi, India)

Source: Annual Congress 2011 - From outside to inside: access to the pleura
Session: From outside to inside: access to the pleura
Session type: Thematic Poster Session
Number: 600
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. S. Jha (New Delhi, India). Low dose vs high dose talc pleurodesis for malignant pleural effusion. Eur Respir J 2011; 38: Suppl. 55, 600

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of talc pleurodesis in patients with malignant pleural effusions
Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions
Year: 2011


Talc slurry vs bleomycin in treatment of malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Efficacy and safety of talc pleurodesis in patients with malignant pleural effusions
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004

Povidone iodine vs. oxytertracycline efficacy in pleurodesis of patients with malignant pleural effusion
Source: International Congress 2018 – Pleural interventions
Year: 2018


Optimal treatment of pleurodesis for malignant pleural effusion in 2017
Source: ERS Skills course - Medical thoracoscopy
Year: 2017

Talc pleurodesis in malignant pleural effusions: A 5-year experience
Source: Annual Congress 2012 - Medical access to the pleura
Year: 2012

Day case rapid pleurodesis in malignant pleural effusion
Source: Virtual Congress 2021 – Novelties in interventional pulmonology
Year: 2021



Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions
Source: Eur Respir J 2004; 24: 263-266
Year: 2004



Malignant pleural effusion: treatment of the fluid and intrapleural therapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Thoracoscopic talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 172s
Year: 2005

Thoracoscopic talc pleurodesis in malignant pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 72s
Year: 2005

Pleurodesis of malignant pleural effusion with OK432
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003

Can serum (CRP) levels estimate the outome of talc pleurodesis in malignant pleural effusions?
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012

Efficacy of rapid pleurodesis in malignat pleural effusions
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010

The profile of neutrophils and D-dimer in pleural fluid is useful to monitor the pleurodesis process after talc poudrage in malignant pleural effusions (MPE)
Source: Eur Respir J 2002; 20: Suppl. 38, 70s
Year: 2002

Malignant pleural effusion: drainage, talc and beyond
Source: International Congress 2019 – PG15 Management of pleural disease in 2019: applying the evidence
Year: 2019


Powder collagen for pleurodesis induction at malignant pleural effusion
Source: Eur Respir J 2005; 26: Suppl. 49, 73s
Year: 2005

Malignant pleural effusions
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=177
Year: 2002